These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 2235893)

  • 21. Calculation of drug-melanin binding energy using molecular modeling.
    Raghavan PR; Zane PA; Tripp SL
    Experientia; 1990 Jan; 46(1):77-80. PubMed ID: 2298284
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction between chemicals and melanin.
    Larsson BS
    Pigment Cell Res; 1993 Jun; 6(3):127-33. PubMed ID: 8234197
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a Phototoxicity Testing Strategy for Accurate Photosafety Evaluation of Pharmaceuticals Based on the Assessment of Possible Melanin-Binding Effects.
    Reinen J; van Sas P; van Huygevoort T; Rubio L; Scase K; Wenker M
    Int J Toxicol; 2018; 37(4):296-307. PubMed ID: 29898631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoradiography in mice of tritiated 2-(2-furyl)benzimidazole and melanin-binding in vitro.
    Frank A; Larsson B; Fabiansson S
    Toxicol Lett; 1983 Jul; 17(3-4):267-73. PubMed ID: 6623521
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Affinity of ocular acid-insoluble melanin for drugs in vitro.
    Tsuchiya M; Hayasaka S; Mizuno K
    Invest Ophthalmol Vis Sci; 1987 May; 28(5):822-5. PubMed ID: 3570692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thallium-201: autoradiography in pigmented mice and melanin-binding in vitro.
    Tjälve H; Nilsson M; Larsson B
    Acta Pharmacol Toxicol (Copenh); 1982 Aug; 51(2):147-53. PubMed ID: 7113721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue distribution of NS-49, a phenethylamine class alpha 1A-adrenoceptor agonist, in pigmented rats.
    Koike T; Kitazumi H; Mukai H
    Arzneimittelforschung; 2001; 51(5):402-7. PubMed ID: 11413741
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of vitreal half-life based on drug physicochemical properties: quantitative structure-pharmacokinetic relationships (QSPKR).
    Durairaj C; Shah JC; Senapati S; Kompella UB
    Pharm Res; 2009 May; 26(5):1236-60. PubMed ID: 18841448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tissue distribution and excretion of myosmine after i.v. administration to Long-Evans rats using quantitative whole-body autoradiography.
    Glas S; Tyroller S; Zwickenpflug W; Steiner K; Kiefer G; Richter E
    Arch Toxicol; 2007 Mar; 81(3):151-61. PubMed ID: 16902802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoradiography of [14C]paraquat or [14C]diquat in frogs and mice: accumulation in neuromelanin.
    Lindquist NG; Larsson BS; Lydén-Sokolowski A
    Neurosci Lett; 1988 Oct; 93(1):1-6. PubMed ID: 3264893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic fate of the new anti-ulcer drug enprostil in animals. 2nd communication: whole-body autoradiographic distribution of [3H]-enprostil in rats.
    Naito K; Nakahara M; Yamada Y; Otsuka M; Takaiti O; Harigaya S; Parnes H; Chaplin M
    Arzneimittelforschung; 1989 Mar; 39(3):342-9. PubMed ID: 2502987
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ex vivo models to evaluate the role of ocular melanin in trans-scleral drug delivery.
    Pescina S; Santi P; Ferrari G; Padula C; Cavallini P; Govoni P; Nicoli S
    Eur J Pharm Sci; 2012 Aug; 46(5):475-83. PubMed ID: 22484210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retention of the cyanobacterial neurotoxin beta-N-methylamino-l-alanine in melanin and neuromelanin-containing cells--a possible link between Parkinson-dementia complex and pigmentary retinopathy.
    Karlsson O; Berg C; Brittebo EB; Lindquist NG
    Pigment Cell Melanoma Res; 2009 Feb; 22(1):120-30. PubMed ID: 19154235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term fate of [14C]nicotine in the mouse: retention in the bronchi, melanin-containing tissues and urinary bladder wall.
    Szüts T; Olsson S; Lindquist NG; Ullberg S; Pilotti A; Enzell C
    Toxicology; 1978 Jul; 10(3):207-20. PubMed ID: 705796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Age-related melanogenesis in the eye of mice, studied by microautoradiography of 3H-methimazole, a specific marker of melanin synthesis.
    Lindquist NG; Larsson BS; Stjernschantz J; Sjöquist B
    Exp Eye Res; 1998 Sep; 67(3):259-64. PubMed ID: 9778406
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of Melanin Characteristics on Drug Binding Properties.
    Jakubiak P; Lack F; Thun J; Urtti A; Alvarez-Sánchez R
    Mol Pharm; 2019 Jun; 16(6):2549-2556. PubMed ID: 30998378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Binding of 14C-spermidine to melanin in vivo and in vitro.
    Tjälve H; Nilsson M; Larsson B
    Acta Physiol Scand; 1981 Jun; 112(2):209-14. PubMed ID: 7315415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics, Distribution, Metabolism, and Excretion of Omadacycline following a Single Intravenous or Oral Dose of 14C-Omadacycline in Rats.
    Lin W; Flarakos J; Du Y; Hu W; He H; Mangold J; Tanaka SK; Villano S
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Melanin affinity of manganese.
    Lydén A; Larsson BS; Lindquist NG
    Acta Pharmacol Toxicol (Copenh); 1984 Aug; 55(2):133-8. PubMed ID: 6437141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Affinity of labetalol for ocular melanin.
    Poynter D; Martin LE; Harrison C; Cook J
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):711-20. PubMed ID: 990153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.